Metabolites of the radiosensitizer nicotinamide are unlikely to contribute to the degree of emesis observed with the parent drug.

David Hirst

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)569-574
Number of pages6
JournalOncology Research - Anticancer drug design
Volume16
Publication statusPublished - 2008

Cite this